Globus Medical Net Tangible Assets Over Time
| GMED Stock | USD 82.94 0.05 0.06% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Globus Medical Performance and Globus Medical Correlation. Globus |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Globus Medical. If investors know Globus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Globus Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 42.231 | Earnings Share 0.62 | Revenue Per Share 18.217 | Quarterly Revenue Growth 0.631 | Return On Assets 0.0473 |
The market value of Globus Medical is measured differently than its book value, which is the value of Globus that is recorded on the company's balance sheet. Investors also form their own opinion of Globus Medical's value that differs from its market value or its book value, called intrinsic value, which is Globus Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Globus Medical's market value can be influenced by many factors that don't directly affect Globus Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Globus Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Globus Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Globus Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Net Tangible Assets Analysis
Compare Globus Medical and related stocks such as Orthofix Medical, CONMED, and Alphatec Holdings Net Tangible Assets Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OFIX | 98.3 M | 98.3 M | 286.2 M | 238.9 M | 238.9 M | 231.4 M | 202.5 M | 232.6 M | 211.1 M | 202.3 M | 212.3 M | 213 M | 218.2 M | 250.9 M | 234.7 M |
| CNMD | 142.7 M | 142.7 M | 159.4 M | 38.5 M | 8.6 M | 16.3 M | (236.6 M) | (185.5 M) | (151.4 M) | (440.4 M) | (410.9 M) | (340.8 M) | (751.7 M) | (676.5 M) | (642.7 M) |
| ATEC | 53.2 M | 53.2 M | (26.8 M) | (26.8 M) | (29 M) | (45.4 M) | (23.6 M) | (8.3 M) | 872 K | 28.7 M | 114.9 M | (45.5 M) | (159.3 M) | (143.3 M) | (136.2 M) |
| LIVN | 247.4 M | 247.4 M | 247.4 M | 247.4 M | 266.4 M | 407.2 M | 573.6 M | 495.7 M | (223.5 M) | (139.6 M) | (241.1 M) | (4.6 M) | 70.3 M | 63.3 M | 116.1 M |
| ITGR | 8.1 M | 8.1 M | 23.7 M | 99 M | 173.3 M | (1.1 B) | (1.2 B) | (1 B) | (584.2 M) | (462.9 M) | (345.6 M) | (377.8 M) | 1.4 B | 1.6 B | 1.7 B |
| IRTC | (81.4 M) | (81.4 M) | (81.4 M) | (81.4 M) | (81.4 M) | (102.5 M) | 91.7 M | 78.7 M | 51.3 M | 134.5 M | 340.8 M | 278.7 M | 238.9 M | 274.8 M | 288.5 M |
| GKOS | (164.8 M) | (164.8 M) | (164.8 M) | (164.8 M) | (164.8 M) | 95.2 M | 117.3 M | 138.2 M | 173.9 M | 673.3 M | 667.4 M | 188.2 M | 530 M | 609.5 M | 640 M |
| BRKR | 384.9 M | 384.9 M | 473.7 M | 613.1 M | 554.3 M | 520.8 M | 486.1 M | 473.2 M | 424.8 M | 491.5 M | 509.6 M | 312.5 M | 1.2 B | 1.4 B | 1.5 B |
| NVRO | 172.1 M | 172.1 M | 172.1 M | 172.1 M | 172.1 M | 234.6 M | 249 M | 249.2 M | 245.5 M | 216.4 M | 388.5 M | 303.6 M | 323.9 M | 372.5 M | 291.2 M |
| PODD | 16.2 M | 16.2 M | (16.3 M) | 69 M | 32.2 M | (8.4 M) | 22.9 M | 114.3 M | 162.1 M | 22.9 M | 535.1 M | 479.9 M | 349.2 M | 401.6 M | 421.7 M |
| INSP | (100.7 M) | (100.7 M) | (100.7 M) | (100.7 M) | (100.7 M) | (100.7 M) | (100.7 M) | (117.8 M) | 164 M | 139.8 M | 229.7 M | 229 M | 496 M | 570.4 M | 598.9 M |
| NVCR | 171.8 M | 171.8 M | 171.8 M | 171.8 M | 97.9 M | 250.8 M | 142.3 M | 113.6 M | 112.3 M | 217.8 M | 476.5 M | 410.5 M | 441.2 M | 507.3 M | 267.8 M |
| NARI | (39.4 M) | (39.4 M) | (39.4 M) | (39.4 M) | (39.4 M) | (39.4 M) | (39.4 M) | (39.4 M) | (39.4 M) | (39.1 M) | 200.3 M | 239.2 M | 417 M | 479.6 M | 503.5 M |
Globus Medical and related stocks such as Orthofix Medical, CONMED, and Alphatec Holdings Net Tangible Assets description
The total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company.My Equities
My Current Equities and Potential Positions
| Globus Medical | GMED |
| Classification | Obamacare Repeal |
| Location | Pennsylvania; U.S.A |
| Exchange | New York Stock Exchange |
USD 82.94
Check out Globus Medical Performance and Globus Medical Correlation. For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide.You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Globus Medical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.